Eliminating Excess Cardiovascular risk in People Living with HIV

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

People living with HIV have two times the risk of having a heart attack compared with the general population. Some of this risk is due to damage cause by inflammation that the HIV virus stimulates, but side effects of anti-HIV medications also play a part. This project will try two new strategies aimed at reducing inflammation and blocking the side effects of anti-HIV medications with the aim of reducing the risk of heart attack in people with HIV.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $402,396.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiretroviral therapy | cardiovascular disease | coagulation | human immunodeficiency virus (HIV) | infectious diseases